OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Paolo Bellavite, Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2023) Vol. 11, Iss. 2, pp. 451-451
Open Access | Times Cited: 27

Antiviral activity of an ACE2-Fc fusion protein against SARS-CoV-2 and its variants
Ernesto Bermúdez-Abreut, Talia Fundora-Barrios, Diana Rosa Hernández Fernández, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0312402-e0312402
Open Access

Blaming the unvaccinated during the COVID-19 pandemic: the roles of political ideology and risk perceptions in the USA
Maja Graso, Karl Aquino, Fan Xuan Chen, et al.
Journal of Medical Ethics (2023) Vol. 50, Iss. 4, pp. 246-252
Open Access | Times Cited: 13

Oncogenesis and autoimmunity as a result of mRNA COVID-19 vaccination
Anthony M. Kyriakopoulos, Greg Nigh, Peter A. McCullough, et al.
Authorea (Authorea) (2024)
Open Access | Times Cited: 3

Major role of S-glycoprotein in providing immunogenicity and protective immunity in mRNA lipid nanoparticle vaccines based on SARS-CoV-2 structural proteins
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis
Weihua Hu, Huanle Cai, Huan-Chang Yan, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2

Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 379-379
Open Access | Times Cited: 1

Persistence of T-Cell Immunity Responses against SARS-CoV-2 for over 12 Months Post COVID-19 Infection in Unvaccinated Individuals with No Detectable IgG Antibodies
Vassiliki Pitiriga, Myrto Papamentzelopoulou, Kanella E. Konstantinakou, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1764-1764
Open Access | Times Cited: 4

Clinical Severity in Different Waves of SARS-CoV-2 Infection in Sicily: A Model of Smith’s “Law of Declining Virulence” from Real-World Data
Emanuele Amodio, Dario Genovese, Alessandra Fallucca, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 125-125
Open Access | Times Cited: 8

COVID-19-Related Age Profiles for SARS-CoV-2 Variants in England and Wales and States of the USA (2020 to 2022): Impact on All-Cause Mortality
Rod Jones, Andrey Ponomarenko
Infectious Disease Reports (2023) Vol. 15, Iss. 5, pp. 600-634
Open Access | Times Cited: 4

Persistence of SARS-CoV-2 IgG Antibody Response among South African Adults: A Prospective Cohort Study
Oladele Vincent Adeniyi, Oyewole Christopher Durojaiye, Charity Masilela
Vaccines (2023) Vol. 11, Iss. 6, pp. 1068-1068
Open Access | Times Cited: 3

Antibodies against SARS-CoV-2 in unvaccinated children hospitalized with COVID-19: An observational cohort study of pre-Omicron and Omicron variants era
Rattapon Uppala, Phanthila Sitthikarnkha, Kiatichai Faksri, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0297991-e0297991
Open Access

The Prevalence and Vaccination Coverage Rates of COVID-19 in Asia: A Cross-sectional Study after Four Years
Ahmad Alrasheedi
Journal of Medical and Health Studies (2024) Vol. 5, Iss. 1, pp. 84-94
Open Access

Epidemiology and clinical characteristics of headache among COVID-19 patients in Lebanon: a retrospective cohort study
Nour Safawi, Jida Hasbini, Hawaa Khodor, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access

Urban wastewater contains a functional human antibody repertoire of mucosal origin
Sean Stephenson, Walaa Eid, Chandler H. Wong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Urban wastewater contains a functional human antibody repertoire of mucosal origin.
Sean Stephenson, Walaa Eid, Chandler H. Wong, et al.
Water Research (2024) Vol. 267, pp. 122532-122532
Open Access

COVID-19 Immunization for Adolescents: What does the Scientific Evidence Tell us?
Banerjee Ak, Sachin Atre
Medical Journal of Dr D Y Patil Vidyapeeth (2024) Vol. 17, Iss. Suppl 2, pp. S261-S262
Open Access

Comparative Analysis of Vaccine-induced Immunity and Natural Immunity in Post-COVID Patients
Saulesh Kurmangalieva, Akzhan M. Madenbayeva, Saltanat T. Urazayeva, et al.
West Kazakhstan Medical Journal (2024) Vol. 66, Iss. 4, pp. 387-400
Open Access

Cellular immunity against SARS-CoV-2 depends on the serological status
Laura Pighi, Brandon Michael Henry, Simone De Nitto, et al.
Journal of Infection (2023) Vol. 87, Iss. 1, pp. 57-58
Open Access | Times Cited: 1

COVID-19-ASSOCIATED CHANGES IN IMMUNITY AND LUNG LESIONS
О. M. Rekalova
Ukrainian Pulmonology Journal (2023) Vol. 31, Iss. 2, pp. 13-23
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top